InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Pacira BioSciences, Inc.

PCRX Clue Score49
United States Fiscal year ends December CIK 0001396814
$36.31 -0.22% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $36.31 −28.47% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue270.1Operating income−32.0Net income−37.9EPS, diluted−1.02Fiscal year 2017Revenue284.3 +5.3%Operating income−24.9Net income−42.6EPS, diluted−1.07Fiscal year 2018Revenue332.4 +16.9%Operating income15.9Net income−0.5EPS, diluted−0.01Fiscal year 2019Revenue418.9 +26.0%Operating income10.5Net income−11.0EPS, diluted−0.27Fiscal year 2020Revenue429.6 +2.6%Operating income46.4Net income145.5EPS, diluted3.33Fiscal year 2021Revenue541.5 +26.0%Operating income89.9Net income42.0 −71.2%EPS, diluted0.92 −72.4%Fiscal year 2022Revenue666.8 +23.1%Operating income60.0Net income15.9 −62.1%EPS, diluted0.34 −63.0%Fiscal year 2023Revenue675.0 +1.2%Operating income87.7Net income42.0 +163.7%EPS, diluted0.89 +161.8%Fiscal year 2024Revenue701.0 +3.9%Operating income−73.4Net income−99.6 −337.3%EPS, diluted−2.15 −341.6%Fiscal year 2025Revenue726.4 +3.6%Operating income19.2Net income7.0EPS, diluted0.16
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 270.1 284.3 332.4 418.9 429.6 541.5 666.8 675.0 701.0 726.4
Growth +5.3% +16.9% +26.0% +2.6% +26.0% +23.1% +1.2% +3.9% +3.6%
Operating income −32.0 −24.9 15.9 10.5 46.4 89.9 60.0 87.7 −73.4 19.2
Net income −37.9 −42.6 −0.5 −11.0 145.5 42.0 15.9 42.0 −99.6 7.0
Growth −71.2% −62.1% +163.7% −337.3%
EPS, diluted −1.02 −1.07 −0.01 −0.27 3.33 0.92 0.34 0.89 −2.15 0.16
Growth −72.4% −63.0% +161.8% −341.6%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−11.9%Net margin−14.1%Free cash flow margin3.2%Fiscal year 2017Operating margin−8.8%Net margin−15.0%Free cash flow margin−0.5%Fiscal year 2018Operating margin4.8%Net margin−0.1%Free cash flow margin10.3%Fiscal year 2019Operating margin2.5%Net margin−2.6%Free cash flow margin14.4%Fiscal year 2020Operating margin10.8%Net margin33.9%Free cash flow margin9.1%Fiscal year 2021Operating margin16.6%Net margin7.8%Free cash flow margin14.7%Fiscal year 2022Operating margin9.0%Net margin2.4%Free cash flow margin17.3%Fiscal year 2023Operating margin13.0%Net margin6.2%Free cash flow margin20.7%Fiscal year 2024Operating margin−10.5%Net margin−14.2%Free cash flow margin25.5%Fiscal year 2025Operating margin2.6%Net margin1.0%Free cash flow margin18.8%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −11.9% −8.8% 4.8% 2.5% 10.8% 16.6% 9.0% 13.0% −10.5% 2.6%
Net margin −14.1% −15.0% −0.1% −2.6% 33.9% 7.8% 2.4% 6.2% −14.2% 1.0%
Free cash flow margin 3.2% −0.5% 10.3% 14.4% 9.1% 14.7% 17.3% 20.7% 25.5% 18.8%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow33.5Capital expenditure−24.7Free cash flow8.7Fiscal year 2017Operating cash flow17.8Capital expenditure−19.3Free cash flow−1.5 −116.9%Fiscal year 2018Operating cash flow48.9Capital expenditure−14.5Free cash flow34.4Fiscal year 2019Operating cash flow70.5Capital expenditure−10.2Free cash flow60.4 +75.7%Fiscal year 2020Operating cash flow77.0Capital expenditure−37.8Free cash flow39.2 −35.0%Fiscal year 2021Operating cash flow125.7Capital expenditure−45.9Free cash flow79.9 +103.5%Fiscal year 2022Operating cash flow145.3Capital expenditure−30.1Free cash flow115.2 +44.3%Buybacks0.0Fiscal year 2023Operating cash flow154.6Capital expenditure−15.2Free cash flow139.5 +21.1%Buybacks0.0Fiscal year 2024Operating cash flow189.4Capital expenditure−10.6Free cash flow178.8 +28.1%Buybacks−25.0Fiscal year 2025Operating cash flow152.0Capital expenditure−15.3Free cash flow136.7 −23.5%Buybacks−148.3
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 33.5 17.8 48.9 70.5 77.0 125.7 145.3 154.6 189.4 152.0
Capital expenditure −24.7 −19.3 −14.5 −10.2 −37.8 −45.9 −30.1 −15.2 −10.6 −15.3
Free cash flow 8.7 −1.5 34.4 60.4 39.2 79.9 115.2 139.5 178.8 136.7
Growth −116.9% +75.7% −35.0% +103.5% +44.3% +21.1% +28.1% −23.5%
Buybacks n/a n/a n/a n/a n/a n/a 0.0 0.0 −25.0 −148.3

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash35.9Total debt227.3Net cash (debt)−191.3Shareholders’ equity219.0Debt to equity1.04Fiscal year 2017Cash54.1Shareholders’ equity279.5Fiscal year 2018Cash132.5Shareholders’ equity321.2Fiscal year 2019Cash78.2Shareholders’ equity354.9Fiscal year 2020Cash100.0Shareholders’ equity619.7Fiscal year 2021Cash585.6Shareholders’ equity730.4Fiscal year 2022Cash104.1Total debt689.5Net cash (debt)−585.3Shareholders’ equity775.0Debt to equity0.89Fiscal year 2023Cash153.3Total debt522.4Net cash (debt)−369.1Shareholders’ equity870.1Debt to equity0.60Fiscal year 2024Cash276.8Total debt585.3Net cash (debt)−308.5Shareholders’ equity778.3Debt to equity0.75Fiscal year 2025Cash158.5Total debt372.2Net cash (debt)−213.6Shareholders’ equity693.1Debt to equity0.54
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 35.9 54.1 132.5 78.2 100.0 585.6 104.1 153.3 276.8 158.5
Total debt 227.3 n/a n/a n/a n/a n/a 689.5 522.4 585.3 372.2
Net cash (debt) −191.3 n/a n/a n/a n/a n/a −585.3 −369.1 −308.5 −213.6
Shareholders’ equity 219.0 279.5 321.2 354.9 619.7 730.4 775.0 870.1 778.3 693.1
Debt to equity 1.04 n/a n/a n/a n/a n/a 0.89 0.60 0.75 0.54

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
270.1 284.3 332.4 418.9 429.6 541.5 666.8 675.0 701.0 726.4
Growth +5.3% +16.9% +26.0% +2.6% +26.0% +23.1% +1.2% +3.9% +3.6%
110.1 87.9 86.8 106.7 117.3 140.3 199.3 184.7 170.4 149.7
45.7 57.3 55.7 72.1 59.4 55.5 84.8 76.3 81.6 117.3
152.6 161.5 177.3 200.8 193.5 199.3 254.5 269.4 294.1 368.8
−32.0 −24.9 15.9 10.5 46.4 89.9 60.0 87.7 −73.4 19.2
Growth −34.2% +342.3% +94.0% −33.3% +46.1% −183.7%
−37.8 −42.5 −0.4 −10.7 20.1 56.4 13.3 61.7 −63.1 16.9
0.1 0.1 0.0 0.3 −125.4 14.4 −2.6 19.7 36.5 9.8
−37.9 −42.6 −0.5 −11.0 145.5 42.0 15.9 42.0 −99.6 7.0
Growth −71.2% −62.1% +163.7% −337.3%
Per share
−1.02 −1.07 −0.01 −0.27 3.41 0.95 0.35 0.91 −2.15 0.16
−1.02 −1.07 −0.01 −0.27 3.33 0.92 0.34 0.89 −2.15 0.16
Growth −72.4% −63.0% +161.8% −341.6%
37.2 39.8 40.9 41.5 42.7 44.3 45.5 46.2 46.2 44.6
37.2 39.8 40.9 41.5 43.7 45.6 46.5 52.0 46.2 45.0
Growth +6.9% +2.8% +1.5% +5.2% +4.5% +2.0% +11.7% −11.0% −2.6%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 11.1% a year over five years, and earnings per share fell 45.5% a year.
  • The diluted share count rose 3.1% in five years, which is dilution.
  • Operating margin is down 8.1 points on five years ago, at 2.6%.
  • A net loss in 5 of 10 years on file.